Skip to Content


Manufacturer of Controlled Substances; Notice of Withdrawal of Application

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

By notice dated February 4, 2004, and published in the Federal Register on February 18, 2004 (68 FR 7656), IRIX Pharmaceuticals, Inc., 101 Technology Place, Florence, South Carolina 29501, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of methylphenidate (1724), a basic class of controlled substance listed in Schedule II.

The firm planned to manufacture methylphenidate for sale to its customers.

By letter dated February 18, 2004, IRIX Pharmaceuticals, Inc., requested that its registration as a Schedule II bulk manufacturer be retired. Therefore, IRIX Pharmaceuticals, Inc's renewal application to import the above listed controlled substance is hereby withdrawn.

Start Signature

Dated: March 29, 2004.

William J. Walker,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. 04-9660 Filed 4-28-04; 8:45 am]